Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Hydrocortisone Medis


May be acceptable
Risk of intrauterine growth retardation and neonatal adrenal insufficiency

May be acceptable
Hydrocortisone Medis :
Type Medicine Rejected
Originator Hydrocortisone Roussel Injectable°
Agent MedisPharm
Distributor MedisPharm
Laboratory Medis
Manufacturer Les Laboratoires Medis SA
Manufacturing Type G
Origin Tunisia
ATC H02AB09
Revision Date 01/10/2012

Your comment will appear shortly after approval

Hydrocortisone Medis :

Revision Date : 31/07/2017


Effect Frequency
Abdominal pain upper Common
Acne Not known
Cataract Not known
Cushing-like symptoms Not known
Diabetes mellitus Not known
Dry eye Common
Dyspepsia Not known
Ecchymosis Not known
Euphoric mood Not known
Fatigue Very Common
Fluid retention Not known
Gastric ulcer Not known
Gastroenteritis Common
Glucose tolerance impaired Not known
HDL cholesterol decreased Common
Hirsutism Not known
Hypertension Not known
Hypokalaemia Not known
Impaired healing Not known
Infection Not known
Insomnia Not known
Intraocular pressure increased Not known
Joint swelling Common
Nausea Common
Oedema Not known
Oesophagitis Common
Osteoporotic fracture Not known
Psychotic disorders Not known
Rash pruritic Common
Sedation Common
Skin striae Not known
Sodium retention Not known
Tooth erosion Common
Upper respiratory tract infection Common
Vertigo Common
Viral infection Common
Weight increased (weight gain) Common

Different Units By MoH Code

Revision Date : 01/10/2012

Hydrocortisone Medis  MoH 2060552 :
Form Powder for solution for injection
Packaging Bottle
Package Size Box of 10
Strength 100mg
Stratum N/A
NSSF ✘
Quarantine ✘
Submission date 30/07/2015
Rejection Year 24/01/2017
Rejection Reason Incomplete study


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info